Clinical Trial

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Name: Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System — clinical trial record (NCT04634916)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CONNECT-AV

Recruiting

View on ClinicalTrials.gov →

Summary

A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.

Protocol Amendment History 1 change

notable Enrollment reduced: 280 -> 220 participants 2026-08-11

Trial Details

NCT Number	NCT04634916
Lead Sponsor	C. R. Bard
Conditions	Kidney Disease, End-Stage, End-stage Renal Disease, Arteriovenous Fistula
Enrollment	220 participants
Start Date	2021-03-26
Primary Completion	2027-06 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-08-10